These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 15385811

  • 1. Long-term outcome of bone mineral density in children who underwent a successful liver transplantation.
    D'Antiga L, Ballan D, Luisetto G, Cillo U, Guariso G, Zancan L.
    Transplantation; 2004 Sep 27; 78(6):899-903. PubMed ID: 15385811
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density and height gain in children with chronic cholestatic liver disease undergoing transplantation.
    D'Antiga L, Moniz C, Buxton-Thomas M, Cheeseman P, Gray B, Abraha H, Baker AJ, Heaton ND, Rela M, Mieli-Vergani G, Dhawan A.
    Transplantation; 2002 Jun 15; 73(11):1788-93. PubMed ID: 12085002
    [Abstract] [Full Text] [Related]

  • 3. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.
    Trautwein C, Possienke M, Schlitt HJ, Böker KH, Horn R, Raab R, Manns MP, Brabant G.
    Am J Gastroenterol; 2000 Sep 15; 95(9):2343-51. PubMed ID: 11007240
    [Abstract] [Full Text] [Related]

  • 4. Influence of tacrolimus and short-duration prednisone on bone mineral density following liver transplantation.
    Scolapio JS, DeArment J, Hurley DL, Romano M, Harnois D, Weigand SD.
    JPEN J Parenter Enteral Nutr; 2003 Sep 15; 27(6):427-32. PubMed ID: 14621125
    [Abstract] [Full Text] [Related]

  • 5. Factors affecting growth after pediatric liver transplantation.
    McDiarmid SV, Gornbein JA, DeSilva PJ, Goss JA, Vargas JH, Martín MG, Ament ME, Busuttil RW.
    Transplantation; 1999 Feb 15; 67(3):404-11. PubMed ID: 10030286
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in the long term after liver transplantation.
    Hamburg SM, Piers DA, van den Berg AP, Slooff MJ, Haagsma EB.
    Osteoporos Int; 2000 Feb 15; 11(7):600-6. PubMed ID: 11069194
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen.
    Mart íG, Gómez R, Jódar E, Loinaz C, Moreno E, Hawkins E.
    Osteoporos Int; 2002 Feb 15; 13(2):147-50. PubMed ID: 11905524
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP, Pirson Y, van Ypersele de Strihou C.
    Transpl Int; 2002 Mar 15; 15(2-3):73-80. PubMed ID: 11935163
    [Abstract] [Full Text] [Related]

  • 9. Bone metabolism in orthotopic liver transplantation: a prospective study.
    Floreani A, Fries W, Luisetto G, Burra P, Fagiuoli S, Boccagni P, Della Rovere GR, Plebani M, Piccoli A, Naccarato R.
    Liver Transpl Surg; 1998 Jul 15; 4(4):311-9. PubMed ID: 9649646
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E, Devogelaer JP, Depresseux G, Squifflet JP, Pirson Y, van Yperselede de Strihou C.
    Clin Nephrol; 2003 Mar 15; 59(3):190-5. PubMed ID: 12653262
    [Abstract] [Full Text] [Related]

  • 11. Evidence of continuing bone recovery at a mean of 7 years after liver transplantation.
    Feller RB, McDonald JA, Sherbon KJ, McCaughan GW.
    Liver Transpl Surg; 1999 Sep 15; 5(5):407-13. PubMed ID: 10477842
    [Abstract] [Full Text] [Related]

  • 12. Bone metabolism in cholestatic children before and after living-related liver transplantation--a long-term prospective study.
    Kryskiewicz E, Pawlowska J, Pludowski P, Ismail H, Karczmarewicz E, Teisseyre M, Skorupa E, Ryzko J, Kalicinski P, Socha J, Lorenc RS.
    J Clin Densitom; 2012 Sep 15; 15(2):233-40. PubMed ID: 22154432
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment.
    Krol CG, Dekkers OM, Kroon HM, Rabelink TJ, van Hoek B, Hamdy NA.
    J Bone Miner Res; 2014 Aug 15; 29(8):1763-9. PubMed ID: 24644003
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density before and after OLT: long-term follow-up and predictive factors.
    Guichelaar MM, Kendall R, Malinchoc M, Hay JE.
    Liver Transpl; 2006 Sep 15; 12(9):1390-402. PubMed ID: 16933236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
    Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J, Buts JP, Sokal E.
    Transplantation; 2001 Jul 27; 72(2):267-72. PubMed ID: 11477351
    [Abstract] [Full Text] [Related]

  • 18. Renal function outcome in pediatric liver transplant recipients.
    Mention K, Lahoche-Manucci A, Bonnevalle M, Pruvot FR, Declerck N, Foulard M, Gottrand F.
    Pediatr Transplant; 2005 Apr 27; 9(2):201-7. PubMed ID: 15787794
    [Abstract] [Full Text] [Related]

  • 19. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Apr 27; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
    Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A.
    Kidney Int; 2000 Oct 27; 58(4):1788-96. PubMed ID: 11012914
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.